Clinical Ink Revenue and Competitors

Claim your profile

Location

$35M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Clinical Ink's estimated annual revenue is currently $72.6M per year.(i)
  • Clinical Ink received $Undisclosed in venture funding in May 2018.
  • Clinical Ink's estimated revenue per employee is $251,250
  • Clinical Ink's total funding is $35M.

Employee Data

  • Clinical Ink has 289 Employees.(i)
  • Clinical Ink grew their employee count by 28% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.1M25-7%N/AN/A
#2
$3.2M160%N/AN/A
#3
$67.1M3346%N/AN/A
#4
$25.5M12755%N/AN/A
#5
$72.6M28928%$35MN/A
#6
$3.3M4048%N/AN/A
#7
$3.1M38-25%N/AN/A
#8
$165.7M21614%$250.7MN/A
#9
$22.3M1114%$637.8KN/A
#10
$44M2198%N/AN/A

Clinical Ink is the leading provider of eSource solutions for the global clinical trials market. Founded in 2007, Clinical Ink® is transforming clinical development with innovative technologies that make clinical research easier for sites, sponsors and patients. Clinical Ink's SureSource® platform directly captures eSource data and documents and improves patient engagement while streamlining clinical development. Clinical Ink maintains offices in Winston-Salem, NC, and Philadelphia, PA. Find more at www.clinicalink.com. Our customer base includes pharmaceutical and medical device companies, academic institutions, and CROs. SureSource has been successfully used in a wide range of therapeutic areas including CNS, infectious diseases, dermatology, gastroenterology, and virology.

keywords:Healthcare,Pharmaceuticals

$35M

Total Funding

289

Number of Employees

$72.6M

Revenue (est)

28%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Clinical Ink News

2022-04-06 - Cutting-Edge Research Reveals Greater Insights into ...

Horsham, PA, April 11, 2022 (GLOBE NEWSWIRE) -- Clinical ink, a global life science technology company, today—World Parkinson's...

2022-03-30 - 85% Accuracy In Early Parkinson's Classification

The Clinical ink team partnered with the University of Rochester and two bio-pharmaceutical companies on WATCH-PD to explore the viability of consumer grade...

2021-06-22 - Empowerment Model: A New Partnership Model for Maximum Efficiency, Cost Savings, and Control, Upcoming Webinar Hosted by Xtalks

Several reputable vendors offer holistic eSource solutions. But what if you want to build and operationalize studies yourself? TORONTO (PRWEB) June 22, 2021 With increased attention on decentralized clinical trials, a growing number of sponsors and CROs plan to adopt direct data capture (DDC), ...

2021-03-18 - Bring Your Own Device: Why the Future of Clinical Trials Lies in Your Patients’ Hands, Upcoming Webinar Hosted by Xtalks

Since smartphones are central to patients’ lives, incorporating them into clinical trials is a logical step toward more reliable and less burdensome electronic patient-reported outcomes (ePRO) collection. TORONTO (PRWEB) March 18, 2021 While bring-your-own-device (BYOD) has been in use for yea ...

2021-02-11 - More Than 100 Companies Adopt eClinical Solutions’ elluminate® Clinical Data Platform to Increase Clinical Trial Efficiency

"With technology platforms like elluminate, we can build on the industry-wide advances made during the pandemic, help manage the data streams coming from decentralized trials and deliver new and important treatments to patients," said Raj Indupuri, Co-Founder and CEO of eClinical Solutions. MAN ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$70.9M2933%N/A
#2
$56.7M31334%N/A
#3
$109.7M325N/AN/A
#4
$53.5M33418%N/A
#5
$105.4M33612%N/A

Clinical Ink Funding

DateAmountRoundLead InvestorsReference
2013-10-17$4.3MBFCA Venture PartnersArticle
2015-03-19$UndisclosedUndisclosedMPM CapitalArticle
2018-05-15$UndisclosedUndisclosedRTI InternationalArticle